Epitope spreading in immune-mediated diseases: implications for immunotherapy
By C. Vanderlugt, S. Miller. Nature reviews. Immunology, 2002
956 citations recorded by the source corpus.
Subfields: Genetics, Immunology
View Paper: https://www.semanticscholar.org/paper/fa6003afa10d5946800b5658f65ca3b5e5330580
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology
Citations in the corpus
- Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis (2005, background): “Epitope spreading is the process by which reactivity to epitopes distinct from and non-crossreactive with the disease-inducing epitope is induced during chronic inflammatory processe”
- New concepts in the immunopathogenesis of multiple sclerosis (2002, neutral): “After the initial CNS tissue damage by autoreactive T cells, the release of myelin antigens could promote immune responses to additional myelin epitopes, starting a cascade of events that culminates in chronic diseas”
- HLA variation and disease (2018, background): “Moreover, even within a single individual, epitope spreading can either contribute to ongoing pathology or even have a protective effect 91 .”
- Myelin Oligodendrocyte Glycoprotein–specific T Cell Receptor Transgenic Mice Develop Spontaneous Autoimmune Optic Neuritis (2003, background): “They may later develop relapsing-remitting disease because of epitope spreading (36).”
- Immunology of multiple sclerosis. (2005, neutral): “Upon EAE induction with whole spinal cord homogenate in SJL/J mice, the dominant T cell response is directed against PLP(139−151), and during disease relapses predictable epitope spreading occurs to PLP(178−191) and later to MBP(89−101) (130, 131).”
- Tumor antigen-specific T helper cells in cancer immunity and immunotherapy (2005, background): “Spreading of the immune response to other antigens, referred to as epitope or determinant spreading, is a phenomenon first discovered in the case of autoimmune disease [58].”